Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2020

May 15, 2020

SELL
$12.31 - $33.12 $24 Million - $64.5 Million
-1,946,800 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$7.26 - $38.49 $14.1 Million - $74.9 Million
1,946,800 New
1,946,800 $66.8 Million
Q3 2019

Nov 14, 2019

SELL
$7.47 - $14.03 $4.54 Million - $8.53 Million
-607,800 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$10.65 - $14.29 $6.47 Million - $8.69 Million
607,800 New
607,800 $7.89 Million

Others Institutions Holding ITCI

About Intra-Cellular Therapies, Inc.


  • Ticker ITCI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 94,401,696
  • Market Cap $7.86B
  • Description
  • Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...
More about ITCI
Track This Portfolio

Track Sio Capital Management, LLC Portfolio

Follow Sio Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sio Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sio Capital Management, LLC with notifications on news.